Clarivate Plc (CLVT)
After hours:
| Previous close | 6.52 |
| Open | 6.64 |
| Bid | 6.36 x 3100 |
| Ask | 6.37 x 3000 |
| Day's range | 6.30 - 6.64 |
| 52-week range | 6.07 - 10.03 |
| Volume | |
| Avg. volume | 4,484,627 |
| Market cap | 4.27B |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
OMRON Selects IPfolio from Clarivate
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that OMRON has selected IPfolio™, an intellectual property management software from Clarivate to transform their IP operations. This solution will enable OMRON, a leading automation company to make smarter decisions and plan strategically using IP data and analytical insights.
- PR Newswire
Clarivate Reports First Quarter 2024 Results
Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2024.
- PR Newswire
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of Epidemiology Intelligence™. The new solution combines rich insights from epidemiology, incidence and prevalence database solutions. It includes U.S. claims-based population insights to empower biopharma companies to accurately gauge market size and target patient demographics with ease.
